Although it is FDA-approved for managing type 2 diabetes, it is often used off-label for weight loss in individuals who meet certain criteria, such as having a body mass index (BMI) of 30 or higher, or 27 and above with weight-related health conditions
(21) In the context of significant weight loss, reduced skeletal loading may lead to an imbalance favoring osteoclastic activity and bone resorption, which could explain the decreased BMD observed in semaglutide-treated patients
Shaw K, Williams SP, Patrick M, ValenciaPrado M, Durkin MS, Howerton EM, Ladd-Acosta CM, Pas ET, Bakian AV, Bartholomew P, Nieves-Muoz N, Sidwell K, Alford A, Bilder DA, DiRienzo M, Fitzgerald RT, Furnier SM, Hudson A, Pokoski OM, Shea L, Tinker SC, Warren Z, Zahorodny W, Agosto-Rosa H, Anbar J, Chvez K, Esler A, Forkner A, Grzybowski A, Agib AH, Hallas L, Lopez M, Magaa S, Nguyen RHN, Parker J, Pierce K, Protho T, Torres H, Vanegas SB, Vehorn A, Zhang M, Andrews J, Greer FL, HallLande J, McArthur D, Mitamura M, Montes A, Pettygrove S, Shenouda J, Skowyra C, Washington A, Maenner MJ (2025) Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 yearsautism and developmental disabilities monitoring network, 16 sites, United States, 2022
The Wegovy pill titration schedule is a gradual journey
Drugwatch (Fill KS, PharmD reviewed)
Frequently Asked Questions Does the 0.25 mg dose of Ozempic leave your system faster than higher doses
